NVAX   $8.47  5.35% Market Closed After Close 8.4094 -0.72%

Novavax Inc
Total Cash 1.05B
totalCashPerShare 6.556
EBITDA -240.84M
Total Debt 263.54M
quickRatio 0.934
currentRatio 1.039
Total Revenue 987.67M
debtToEquity
Revenue/Share 7.659
ROA -0.10212
ROE
grossProfits
freeCashflow -97.84M
operatingCashflow 14.28M
earningsGrowth 0.71
revenueGrowth -0.021
grossMargins 0.16174999
ebitdaMargins -0.24385001
operatingMargins 0.39014
profitMargins -0.29801
enterpriseValue 725.23M
forwardPE -54.6175
floatShares 143.30M
sharesOutstanding 160.09M
sharesShort 35.72M
sharesShortPriorMonth 33.53M
dateShortInterest
sharesPercentSharesOut 0.22%
heldPercentInsiders 0.04%
heldPercentInstitutions 0.55%
Short Ratio help_outline 5.59%
shortPercentOfFloat 0.28%
impliedSharesOutstanding
bookValue -2.7
Price To Book help_outline
earningsQuarterlyGrowth 1.80
netIncomeToCommon -294.33M
trailingEps -2.62%
forwardEps -0.16%
enterpriseToEbitda -3.01
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.83 3Q 2024
institutionsCount 311
lastUpdated Nov. 6, 2024, 7:21 p.m.